The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
Clinical trial NCT06022250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06022250
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-26
- Primary completion
- 2026-04-08
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.